- Home
- KNSA vs TIC Comparison
KNSA vs TIC Comparison
Compare KNSA & TIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- TIC
- Stock Information
- Founded
- KNSA 2015
- TIC 1991
- Country
- KNSA United Kingdom
- TIC United States
- Employees
- KNSA N/A
- TIC N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- TIC
- Sector
- KNSA Health Care
- TIC
- Exchange
- KNSA Nasdaq
- TIC Nasdaq
- Market Cap
- KNSA 1.9B
- TIC 1.5B
- IPO Year
- KNSA 2018
- TIC N/A
- Fundamental
- Price
- KNSA $27.36
- TIC $10.52
- Analyst Decision
- KNSA Strong Buy
- TIC Hold
- Analyst Count
- KNSA 5
- TIC 1
- Target Price
- KNSA $38.80
- TIC $11.50
- AVG Volume (30 Days)
- KNSA 474.9K
- TIC 722.5K
- Earning Date
- KNSA 07-22-2025
- TIC 05-27-2025
- Dividend Yield
- KNSA N/A
- TIC N/A
- EPS Growth
- KNSA N/A
- TIC N/A
- EPS
- KNSA N/A
- TIC N/A
- Revenue
- KNSA $481,166,000.00
- TIC $1,108,546,000.00
- Revenue This Year
- KNSA $37.21
- TIC $4.52
- Revenue Next Year
- KNSA $5.32
- TIC $5.23
- P/E Ratio
- KNSA N/A
- TIC N/A
- Revenue Growth
- KNSA 59.45
- TIC 9.12
- 52 Week Low
- KNSA $17.38
- TIC $8.76
- 52 Week High
- KNSA $28.56
- TIC $14.28
- Technical
- Relative Strength Index (RSI)
- KNSA 62.48
- TIC N/A
- Support Level
- KNSA $26.28
- TIC N/A
- Resistance Level
- KNSA $27.90
- TIC N/A
- Average True Range (ATR)
- KNSA 0.99
- TIC 0.00
- MACD
- KNSA -0.07
- TIC 0.00
- Stochastic Oscillator
- KNSA 82.30
- TIC 0.00
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.